Evidence map›Paper›PMID 36975173›Full record

ReviewHistology and histopathology2023

Extra-meningeal solitary fibrous tumor: an evolving entity with chameleonic morphological diversity, a hallmark molecular alteration and unresolved issues in risk stratification assessment.

Isidro Machado, Francisco Giner, Julia Cruz, Javier Lavernia, Ana Marhuenda-Fluixa, Reyes Claramunt, José Antonio López-Guerrero, Samuel Navarro, Antonio Ferrandez, Álvaro Blázquez Bujeda and 2 more

Abstract readReview
PubMed Publisher
In one paragraph

Review in Histology and histopathology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Isidro Machado *Pathology Department, Instituto Valenciano de Oncología, Valencia, Spain. Isidro.machado@uv.es.
Francisco Giner *Pathology Department, University Hospital "La Fe", Valencia, Spain.
Julia CruzPathology Department, Instituto Valenciano de Oncología, Valencia, Spain.
Javier LaverniaDepartment of Oncology, Instituto Valenciano de Oncología, Valencia, Spain.
Ana Marhuenda-FluixaDepartment of Radiology, Instituto Valenciano de Oncología, Valencia, Spain.
Reyes ClaramuntMolecular Biology Laboratory, Instituto Valenciano de Oncología, Valencia, Spain.
José Antonio López-GuerreroMolecular Biology Laboratory, Instituto Valenciano de Oncología, Valencia, Spain.
Samuel NavarroPathology Department, University of Valencia, Valencia, Spain.
Antonio FerrandezPathology Department, University of Valencia, Valencia, Spain.
Álvaro Blázquez BujedaSchool of Medicine, University of Valencia, Valencia, Spain.
Amparo Ruiz-SauriPathology Department, University of Valencia, Valencia, Spain.
Antonio Llombart-BoschPathology Department, University of Valencia, Valencia, Spain.
Fundación Instituto Valenciano de Oncología · ESUniversitat de València · ESHospital Universitari i Politècnic La Fe · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Solitary fibrous tumor (SFT) is a rare type of mesenchymal lesion with variable clinical presentation in which specific clinicopathologic factors have been related to patient outcome. SFT shares an important morphologic and immunohistochemical overlap with other sarcomas, hence the differential diagnosis is challenging. Although molecular studies provide significant clues, especially in the differential diagnosis with other neoplasms, a thorough hematoxylin and eosin analysis and the integration of phenotypical, clinical, and radiological features remain an essential tool in SFT diagnosis. In this review, we discuss some emerging issues still under debate in SFT.

Indexed as

HemangiopericytomaLizardsMeningeal NeoplasmsSoft Tissue NeoplasmsSolitary Fibrous TumorsAnimalsDiagnosis, DifferentialHumansRisk Assessment

Identifiers

PMID36975173
OpenAlexW4361190839

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.